Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis.
Roy M FleischmannAmy E BockWuyan ZhangCharles M GodfreyIvana VranicCarol CronenbergerEva DokoupilováPublished in: Rheumatology and therapy (2022)
ClinicalTrials.gov identifier: NCT02480153; EudraCT number: 2014-000352-29.